Specification sheet
CJC-1295 w/o DAC + Ipamorelin
- Molecular weight
- 3367.9 / 711.9
- Components
- CJC-1295 (no DAC) + Ipamorelin
- CAS number
- 863288-34-0 / 170851-70-4
- Type
- Peptide blend
- Form
- Lyophilized powder
- Sizes
- 10mg
Research access
Lumen supplies research compounds to qualified researchers and laboratories for in-vitro use. Confirm once to enter.
By entering you affirm the statement above is true. Products are not for human or veterinary use, not for diagnostic procedures, and have not been evaluated by the FDA.
99.88%HPLC purity
Research Blends
Classic secretagogue research pairing.
$80.0010mg vial
Buy 1, get 1 free: add a 2nd vial and it is free.
Researchers also added
Mix and match: Buy 1, get 1 free pairs any two vials in your cart. Research use only.
The compound
A two-component research blend of CJC-1295 (without DAC, 5mg) and Ipamorelin (5mg) - the classic GHRH-analog plus ghrelin-receptor secretagogue pairing, documented per component. Research use only.
Specification sheet
Where it is studied
Pairs a GHRH analog with a selective GH secretagogue frequently co-studied in GH-axis research; see the COA for per-component data.
In the lab
CJC-1295 without DAC is a GRF(1-29) analog, a class studied at the pituitary GRF receptor, and ipamorelin releases growth hormone through the GHRP (ghrelin) receptor. The two have been studied separately; no paper has tested them together.

Compound
CJC-1295 w/o DAC + IpamorelinBlend of CJC-1295 (no DAC) and ipamorelinPituitary receptor
Endpoint studied
Cyclase activationIn 30 GRF(1-29) analogs, the C-terminal part set receptor recognition, the N-terminal part cyclase activation.Robberecht 1986 · PMID 3018703 (opens PubMed in a new tab)Selective GH release
Endpoint studied
GH releaseReleased GH from pituitary cells as potently as GHRP-6; ACTH and cortisol did not rise in laboratory models.Raun 1998 · PMID 9849822 (opens PubMed in a new tab)Research history
5 milestones, each linked to its PubMed record.
1984
CJC-1295
Biochemical and Biophysical Research Communications
[D-Ala2]-GRF(1-29)-NH2 releases GH about 50 times more potently than the parent peptide in laboratory models.
PubMed · PMID 6231028 (opens in a new tab)1986
CJC-1295
Peptides
Thirty GRF(1-29) analogs are tested on pituitary GRF receptors and adenylate cyclase in membrane preparations.
PubMed · PMID 3018703 (opens in a new tab)1991
CJC-1295
European Journal of Pharmacology
Helix-favoring Ala8 and Ala15 substitutions, with D-Ala2, raise GH release potency in pituitary cells additively.
PubMed · PMID 1806385 (opens in a new tab)1998
Ipamorelin
European Journal of Endocrinology
A pentapeptide from a GHRP-1 chemistry program releases GH like GHRP-6 but leaves ACTH and cortisol unchanged.
PubMed · PMID 9849822 (opens in a new tab)1999
Ipamorelin
Growth Hormone & IGF Research
Raised the longitudinal bone growth rate in a growth model, with total IGF-I unchanged.
PubMed · PMID 10373343 (opens in a new tab)Laboratory research only, cited for research context. Not a claim about use in people.
Catalog peptides are specified at 99%+ identity purity. Each lot is verified by an independent laboratory using HPLC and mass spectrometry, and the results are published in that lot's Certificate of Analysis.
A COA is the lab document issued for a specific production lot. It records the compound's identity confirmation, measured purity and the lot number, so the vial on the bench can be traced back to its test results.
Orders placed before the daily cutoff ship the same or next business day from a US facility. Lyophilized peptides are stable in transit and do not require cold shipping.
L-H2O is a sterile, USP-grade laboratory solvent containing 0.9% benzyl alcohol. It is a bench accessory, not a peptide, and carries no HPLC purity claim or COA.
Research use only. Sold strictly for in-vitro laboratory research by qualified professionals. Not for human or veterinary use, not for diagnostic or therapeutic procedures, and not evaluated by the FDA.